化学显色法分析喷墨打印机黑色墨水的种类

目的建立化学显色法检验喷墨打印机字迹色痕的方法。方法选用不同的试剂或混合试剂,对22种不同品牌的喷墨打印黑色墨水的溶解性及与不同试剂的颜色反应进行观察。结果不同品牌的喷墨打印机黑色墨水的溶解性不同,与不同试剂作用会显现不同的颜色。结论化学显色法快速、简便,可用于现场的快速检验。     

国产Goldeneye~(TM) 20A试剂盒性能指标验证

目的测试国产GoldeneyeTM20A试剂盒技术性能指标,评估其法医学应用能力。方法从方法学验证、准确性、峰值均衡性、灵敏度、批次间试剂及稳定性测试、耐受性、不同检材的适应性与一致性、种属特异性、混合样本等9个方面对GoldeneyeTM20A试剂盒进行测试。结果阳性DNA样本分型正确,内标和等位基因分型标准物符合要求;等位基因间的均衡性≥83%,同一荧光标记基因座间的均衡性≥55%,不同标记物间的均衡性≥52%;0.125ng DNA阳性样本可检出全部STR基因座分型,不同批次间和反复冻融后试剂盒测试可以获得正确分型,对降解检材和混有抑制剂的样本等具有一定的耐受性,能对案件中多种检材进行分型且分型结果一致,具有一定的种属特异性和混合DNA样本检测能力。结论国产GoldeneyeTM 20A试剂盒可用于法庭科学实际检案与建库。     

D6S1043和D12S391基因座在亲权鉴定中的应用

目的研究D6S1043和D12S391基因座在亲权关系鉴定案件中的应用价值。方法应用荧光标记复合扩增系统对日常检案中所收集的192名汉族无关个体血样DNA进行PCR扩增,用ABI3100-Avant遗传分析仪对扩增产物进行毛细管电泳,用GeneMapperv3.2软件进行基因分型,统计分析D6S1043和D12S391基因座的多态信息。结果在D6S1043和D12S391基因座分别发现12个等位基因,它们在中国汉族人群中的个体识别能力分别为0.9656和0.9510,二联体非父排除率分别为0.573和0.510,三联体非父排除率分别为0.731和0.679。结论D6S1043和D12S391基因座具有高度多态性,在亲权鉴定中具有重要应用价值。     

招警体能测试的应试训练方法研究

招警体能测试是公务员招录的一项重要考核内容,考生遭淘汰的主要原因是:训练时间短、心理压力大、缺乏适应性训练等。因此,充分掌握体能测试项目的测试方法和技术要领,加强科学训练,才能使考生稳定发挥成绩,提高招警体能测试通过率。     

行政法治与中国上海 自由贸易试验区政府职能转变

建立中国（上海）自由贸易试验区是在新形势下推进改革开放的重大举措,对加快政府职能转变、探索管理模式创新,具有重要意义。自由贸易试验区政府职能转变必须按照法治政府建设的要求,深化管理机构改革,不断推进行政立法完善,探索合理、有效的行政执法模式,完善行政相对人的权利救济制度。     

随机模拟法进行单亲累积亲权指数分析

目的以随机模拟法进行大量单亲累积亲权指数(CPI)统计分析。方法针对Identifiler、PP18D、PP21、AGCU EX20、AGCU 21+1等5个试剂盒,使用自主研发软件,随机模拟100万组单亲组合并计算单亲PI,统计各试剂盒单亲极低CPI比率(R_(VLCPI))、各基因座的PI中位数(M_(PI))和39个基因座的平均单基因座单亲PI(PI_(solo)),并推导增加检测的基因座个数(N)的计算公式。结果 Identifiler、PP18D、AGCU EX20、PP21、AGCU EX20AGCU 21+1的R_(VLCPI)分别为24.9%、6.5%、1.4%、0.7%、0.000 1%。在各试剂盒的基因座存在包含关系的前提下,R_(VLCPI)和常染色体基因座数成负相关。PI_(solo)为1.843 2。M_(PI)与PE_(duo)呈显著的正相关(r=0.956,P0.001)。增加检测的基因座个数公式为N=「log_(1.843 2)(10 000/P)■。结论本文结果和公式对单亲鉴定案具有一定的应用价值。     

导学案“三驾马车”拉启活力课堂——研学后教导学案教学模式在高中政治学科教学中的应用

本文基于建构主义学习理论,探讨高中政治活力课堂导学案的设计,建构了预习案、探究案和拓展检测案"三驾马车",以拉启活力课堂。预习案主要从学习目标的设计、学法指导、知识准备和导学新知四个方面对于学生的课前自主学习做了分析。探究案主要从问题讨论、归纳总结和梯度训练三个方面对于学生课堂中合作探究和自我内化做了分析。拓展检测案主要从拓展延伸和达标检测两个方面对于学生课后复习建构做了分析。上述导学案的建构,力求在教学实践中具有实用价值。     

探讨EOS染色剂对血迹DNA检验的影响

目的探讨被EOS染色剂处理后的血迹进行DNA检验的初步方法。方法制备EOS染色剂处理的血迹样本，分别采取纯水擦拭、75％酒精擦拭，或手术刀刮取血痕浸泡于纯水中、759／5酒精中，然后提取DNA进行下一步检测。结果采用刀刮取血痕浸泡于759／6酒精中，提取的DNA检测结果较好。结论初步实验显示，经EOS染色剂处理过的血迹，可参考刀刮取血迹置于75％酒精浸泡后提取DNA做下一步检测。     

HLA区域SNPs及其在法医学中的应用价值

人类白细胞抗原是迄今为止人类发现的最复杂的基因系统。HLA区域SNPs的分布频率高于人类整个基因组水平达到8.6%。目前SNPs可用多种方法检测。本文主要综述HLA区域SNPs在法医学亲权鉴定和个人识别的应用价值。     

Eu merger control and the compatibility test:a review of recent developments

The compatibility test contained in Article 2 of the Merger Control Regulation (MCR) is at the very heart of EU merger control, for it determines whether a concentration with a community dimension is deemed compatible or incompatible with the common market. Incompatibility can lead to prohibition of a concentration, although this is rare. The paper reviews the recent developments to the conditions of the test itself as well as the analytical methods employed to determine compatibility. Concerning the former, the new foreseeable dominance interpretation, put forward by the European Commission and made law by the Court of First Instance (CFI), is explored. This new variant of the dominance condition is important on its own right but it is also of major interest because of the explicit legal requirement placed on the Commission to assess the future likelihood of abusive behaviour by the merging parties in its prospective analysis. This is not the case with the original dominance compatibility condition. The unexpected but important clarification by the CFI of the notion of substantial part of the common market, as contained in the express wording of the compatibility test, is also commented upon. Concerning the determination of compatibility, the Commission's controversial employment in certain conglomerate concentrations of the range effects of competitive harm theory is examined, as is the need to take cognisance of merger specific efficiencies when determining if a merger increases societal welfare. The EU is making progress toward such an efficiencies assessment as part of the compatibility determination. EU merger control – and hence the compatibility test – do not exist in a vacuum. The EU has played a major role in shaping the new multilateral architecture and its goal of increasing international convergence in competition matters. This in turn has led the EU to rethink the nature of the compatibility test. For example, it has sought to evaluate the dominance condition of the compatibility test with the substantial lessening of competition (SLC) approach used by some other regulators, like the US. The paper concludes by looking at a fundamental issue that has arisen from recent CFI judgements and the GE/Honeywell merger: the competence of the Commission, or more accurately the Merger Task Force (MTF), to carry out the compatibility determination. Proposals are outlined so as to ensure that the Commission's prospective analysis in a concentration case meets the requisite legal standard. It is essential for this standard to be met if EU merger control is to remain credible. This revised version was published online in July 2006 with corrections to the Cover Date.